# Responsible Person

## Header

Item    |   Details
----    |   ----
Purpose | Deﬁne the roles and responsibilities of the Responsible Persons (RP).
Departments | Quality
Categories    | GDP

## References and Associated Documents

### Additional References

* Guidelines on Good Distribution Practice of Medicinal Products for Human Use (2013/C 343/01)
* [EC Directive 2001/83/EC as amended][EC 2001/83/EC]
* [Medicinal Products (Control of Wholesale Distribution) (Amendment) Regulations 2013 (S.I. No. 164/2013)](http://www.irishstatutebook.ie/eli/2013/si/164/made/en/print)
* Falsiﬁed Medicines Directive 2011/62/EU

### Associated Documents

* Form Delegation of RP and Deputy RP Duties

## Roles

Role        |   Description    |   Who
------      |   --------       |  ----
Management  |  Appoints Responsible Persons | Leadership
Responsible Person  | Responsible for compliance with GDP | RP 


## Procedure

All Responsible Persons listed on the company's Wholesale Distribution Authorisation have the job description outlining their responsibilities as follows.

* To ensure that the provisions of the license are observed.
* Ensuring that a quality management system is implemented and maintained.
* Reviewing procedures in relation to the operation of the Wholesale Distribution Authorisation
* Overseeing audit of the quality system on a regular basis as per procedure [Self-inspections][GMQHI].
* Ensuring that accurate records are made.
* Ensuring that data is backed-up with a 5 year minimum retention period at a secure location.
* Ensure that customers and suppliers are approved as per procedure [Establishing the authority of suppliers to supply medicinal products][AGTXC] prior to commencing trade.
* Ensuring that customer complaints are dealt as per procedure [Customer complaints][ZIWKI]
* Ensuring that there is a system in place for handling returned goods as per procedure [Medicinal Product Returns][BMAXZ].
* Participating in recall decision and support product recalls as per [Recall procedure][VOZWP].
* Ensuring that a procedure is in place to handle suspected falsified medicinal products as per [Falsified Medicinal Products][VTOMR].
* Ensuring that the final disposition of returned, recalled or falsified products is performed in accordance with the relevant procedures referenced above.
* Ensuring that all personnel are trained and that continuous training programmes are maintained as per [Training][ZWJPR].
* Ensuring that the selection, approval and management of GDP outsourced and delegated activities are performed as per [Outsourced activities][HBQIN].
* Being involved in communications with the Regulatory Authority with respect to activities as they apply to the Wholesale Distribution Authorisation (WDA).
* The RP shall be contactable at all times and shall provide the Regulatory Authority with the appropriate contact details.
* The RP shall keep themselves up to date with any changes in the legislation and with on—going training as identified.
* Ensuring that deviations are investigated appropriately in a timely manner as per [Deviations][XCEUG], and that the required CAPA(s) is implemented and monitored for effectiveness in accordance with [CAPA][YUISV].
* Ensuring that changes are managed through [UYNEF Change control].
* Ensuring that new products are introduced in compliance with the Licence and Guidelines on Good Distribution Practice for medicinal product for human use (2013/C343/01), and that the new product has been appropriately classified e.g., medicinal product, medical device, food supplement, cosmetic, biocide. etc. aand that the category is authorised under the WDA

[EC 2001/83/EC]: https://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:C:2013:343:0001:0014:EN:PDF
[AMXWS]: /procedures/Procedure_GDP_AMXWS_Management_of_Standard_Operating_Procedures.md
[XIDEX]: /procedures/Procedure_GDP_XIDEX_Responsible_Person.md
[BWRPX]: /procedures/Procedure_GDP_BWRPX_Documentation_Control.md
[XCEUG]: /procedures/Procedure_GDP_XCEUG_Deviations.md
[UYNEF]: /procedures/Procedure_GDP_UYNEF_Change_control.md
[OZCFN]: /procedures/Procedure_GDP_OZCFN_Management_review_and_monitoring.md
[LBHIY]: /procedures/Procedure_GDP_LBHIY_Quality_Risk_Management.md
[ZWJPR]: /procedures/Procedure_GDP_ZWJPR_Training.md
[VQICE]: /procedures/Procedure_GDP_VQICE_Receipt_of_medicinal_products.md
[AGTXC]: /procedures/Procedure_GDP_AGTXC_Establishing_the_authority_of_suppliers_to_supply_medicinal_products.md
[ZIWKI]: /procedures/Procedure_GDP_ZIWKI_Customer_complaints.md
[VOZWP]: /procedures/Procedure_GDP_VOZWP_Recall_procedure.md
[HBQIN]: /procedures/Procedure_GDP_HBQIN_Outsourced_activities.md
[GMQHI]: /procedures/Procedure_GDP_GMQHI_Self-inspections.md
[VTOMR]: /procedures/Procedure_GDP_VTOMR_Falsified_Medicinal_Products.md
[GGNHM]: /procedures/Procedure_GDP_GGNHM_Reporting_of_Adverse_Events.md
[BMAXZ]: /procedures/Procedure_GDP_BMAXZ_Medicinal_Product_Returns.md
[YUISV]: /procedures/Procedure_GDP_YUISV_CAPA.md
[QEAIC]: /procedures/Document_QEAIC_Glossary.md